National Health Investors, Inc. (NYSE:NHI – Get Free Report) has been given an average rating of “Moderate Buy” by the ten brokerages that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among brokers that have covered the stock in the last year is $79.11.
Several equities analysts have commented on NHI shares. National Bank Financial set a $79.00 target price on shares of National Health Investors in a research note on Wednesday, September 9th. Zacks Research raised shares of National Health Investors from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 29th. Wells Fargo & Company decreased their price objective on shares of National Health Investors from $68.00 to $65.00 and set an “equal weight” rating for the company in a report on Monday, November 16th. BMO Capital Markets reiterated an “outperform” rating on shares of National Health Investors in a report on Wednesday, September 23rd. Finally, Huntington initiated coverage on shares of National Health Investors in a research note on Monday, November 9th. They set a “strong-buy” rating on the stock.
Read Our Latest Research Report on NHI
Insider Activity at National Health Investors
In related news, CEO D. Eric Mendelsohn purchased 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, November 17th. The stock was acquired at an average price of $60.53 per share, for a total transaction of $90,795.00. Following the transaction, the chief executive officer directly owned 134,816 shares of the company’s stock, valued at $8,160,412.48. This trade represents a 1.13% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 2.70% of the company’s stock.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the business. EverSource Wealth Advisors LLC increased its stake in National Health Investors by 34.3% in the 1st quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust’s stock valued at $51,000 after buying an additional 160 shares during the period. Assetmark Inc. lifted its position in National Health Investors by 13.5% in the 1st quarter. Assetmark Inc. now owns 1,356 shares of the real estate investment trust’s stock worth $110,000 after buying an additional 161 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of National Health Investors by 38.0% during the 3rd quarter. GAMMA Investing LLC now owns 603 shares of the real estate investment trust’s stock valued at $40,000 after buying an additional 166 shares during the period. Cetera Investment Advisers boosted its stake in shares of National Health Investors by 2.2% during the 3rd quarter. Cetera Investment Advisers now owns 9,198 shares of the real estate investment trust’s stock valued at $604,000 after buying an additional 200 shares during the period. Finally, Versant Capital Management Inc boosted its stake in shares of National Health Investors by 108.5% during the 3rd quarter. Versant Capital Management Inc now owns 415 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 216 shares during the period. 62.51% of the stock is owned by institutional investors and hedge funds.
National Health Investors Price Performance
Shares of NYSE:NHI opened at $61.30 on Friday. The company has a quick ratio of 13.59, a current ratio of 13.59 and a debt-to-equity ratio of 0.50. National Health Investors has a fifty-two week low of $59.05 and a fifty-two week high of $91.38. The firm has a 50-day simple moving average of $66.37 and a 200 day simple moving average of $75.37. The company has a market cap of $3.01 billion, a PE ratio of 4.30, a P/E/G ratio of 3.90 and a beta of 0.51.
National Health Investors (NYSE:NHI – Get Free Report) last issued its quarterly earnings data on Monday, November 9th. The real estate investment trust reported $11.47 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $10.29. National Health Investors had a return on equity of 41.41% and a net margin of 152.82%. The firm had revenue of $113.48 million during the quarter, compared to the consensus estimate of $68.53 million. On average, sell-side analysts anticipate that National Health Investors will post 4.72 EPS for the current year.
National Health Investors Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 31st will be paid a dividend of $0.92 per share. The ex-dividend date of this dividend is Thursday, December 31st. This represents a $3.68 annualized dividend and a yield of 6.0%. National Health Investors’s dividend payout ratio is currently 26.40%.
About National Health Investors
National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee. NHI’s portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans. The company serves markets across the United States.
Featured Articles
- Five stocks we like better than National Health Investors
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
